Yanqing Gong

3.6k total citations
115 papers, 2.4k citations indexed

About

Yanqing Gong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yanqing Gong has authored 115 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 51 papers in Pulmonary and Respiratory Medicine and 38 papers in Cancer Research. Recurrent topics in Yanqing Gong's work include Bladder and Urothelial Cancer Treatments (27 papers), Renal cell carcinoma treatment (21 papers) and Ferroptosis and cancer prognosis (21 papers). Yanqing Gong is often cited by papers focused on Bladder and Urothelial Cancer Treatments (27 papers), Renal cell carcinoma treatment (21 papers) and Ferroptosis and cancer prognosis (21 papers). Yanqing Gong collaborates with scholars based in China, United States and India. Yanqing Gong's co-authors include Liqun Zhou, Shiming He, Xuesong Li, Xuesong Li, Anbang He, Peng Ding, Kan Gong, Yonghao Zhan, Bao Guan and Zhicong Chen and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yanqing Gong

109 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanqing Gong China 30 1.4k 884 507 502 430 115 2.4k
Xiangsong Wu China 30 1.6k 1.1× 914 1.0× 568 1.1× 329 0.7× 568 1.3× 74 2.5k
Chun‐Dong Zhang China 26 1.1k 0.8× 600 0.7× 525 1.0× 462 0.9× 348 0.8× 115 2.1k
Zhonghua Xu China 26 1.0k 0.7× 555 0.6× 436 0.9× 419 0.8× 285 0.7× 88 1.9k
Minfeng Chen China 25 1.3k 0.9× 607 0.7× 465 0.9× 439 0.9× 278 0.6× 85 2.2k
Jian Dong China 26 939 0.7× 527 0.6× 586 1.2× 306 0.6× 454 1.1× 96 2.4k
Chunyan Gu China 24 1.5k 1.1× 678 0.8× 295 0.6× 276 0.5× 368 0.9× 93 2.3k
Yan Xie China 25 1.3k 1.0× 556 0.6× 301 0.6× 434 0.9× 249 0.6× 93 2.5k
Rui Liu China 24 1.5k 1.1× 937 1.1× 336 0.7× 281 0.6× 209 0.5× 93 2.4k

Countries citing papers authored by Yanqing Gong

Since Specialization
Citations

This map shows the geographic impact of Yanqing Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqing Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqing Gong more than expected).

Fields of papers citing papers by Yanqing Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanqing Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqing Gong. The network helps show where Yanqing Gong may publish in the future.

Co-authorship network of co-authors of Yanqing Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Yanqing Gong. A scholar is included among the top collaborators of Yanqing Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanqing Gong. Yanqing Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rui, Rui, Cong Huang, Yucai Wu, et al.. (2025). Metallothionein 1X is a tumor suppressor gene and inhibits oxidative stress and metastasis in renal cell carcinoma. Discover Oncology. 16(1). 1545–1545.
2.
Zhang, Jianye, Qi Zhang, Ying Wang, et al.. (2025). Single‐Cell Analysis Reveals that Vitamin C Inhibits Bone Metastasis of Renal Cancer via Cell Cycle Arrest and Microenvironment Remodeling. Advanced Science. 12(30). e01011–e01011. 1 indexed citations
3.
Liu, Hao, Zhenhao Liu, Yanqing Gong, et al.. (2025). Low physical activity-related disease burden, 1990–2021: assessment of global trends and social determinants based on GBD 2021 data. Journal of Global Health. 15. 4314–4314.
4.
Zhang, Zedan, Yi Wang, Wuping Yang, et al.. (2024). Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort. iScience. 27(7). 110357–110357.
5.
Gong, Yanqing, et al.. (2024). Abdomen Malignant Myxoid Leiomyosarcoma with PDGFRA and TP53Missense Mutation: A Case Report. Current Cancer Therapy Reviews. 20(5). 517–521.
6.
Yang, Wuping, Zedan Zhang, Lei Li, et al.. (2023). ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation. Cell Death and Disease. 14(3). 212–212. 9 indexed citations
7.
Zhang, Kenan, Wuping Yang, Zedan Zhang, et al.. (2022). A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma. Journal of Oncology. 2022. 1–19. 4 indexed citations
8.
Zhang, Zedan, Wuping Yang, Yawei Xu, et al.. (2022). Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma. Journal of Immunology Research. 2022. 1–19. 8 indexed citations
9.
Zhang, Kenan, Wuping Yang, Kaifang Ma, et al.. (2022). Genotype–phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions. Journal of Medical Genetics. 60(5). 477–483.
10.
Hong, Fei, Ming Shi, Jiang Cao, et al.. (2021). Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia. Journal of Cellular and Molecular Medicine. 25(24). 11063–11074. 23 indexed citations
11.
Xie, Haibiao, Kaifang Ma, Kenan Zhang, et al.. (2021). Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway. Cell Death and Disease. 12(1). 1–1. 123 indexed citations
12.
Xu, Yawei, Lei Li, Wuping Yang, et al.. (2021). Association between vasectomy and risk of prostate cancer: a meta-analysis. Prostate Cancer and Prostatic Diseases. 24(4). 962–975. 4 indexed citations
13.
Zhang, Kenan, Wuping Yang, Kaifang Ma, et al.. (2021). Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients. Journal of Medical Genetics. 59(10). 951–956. 5 indexed citations
14.
Chen, Xun, Shuai Yan, Fan Yu, et al.. (2021). Hyperspectral stimulated Raman scattering microscopy facilitates differentiation of low-grade and high-grade human prostate cancer. Journal of Physics D Applied Physics. 54(48). 484001–484001. 5 indexed citations
15.
Yang, Wuping, Lei Li, Kenan Zhang, et al.. (2020). CLDN10 Associated with Immune Infiltration is a Novel Prognostic Biomarker for Clear Cell Renal Cell Carcinoma. Epigenomics. 13(1). 31–45. 15 indexed citations
16.
Yang, Fan, et al.. (2020). Stereotactic radiosurgery for central nervous system hemangioblastoma in von Hippel-Lindau disease: A systematic review and meta-analysis. Clinical Neurology and Neurosurgery. 195. 105912–105912. 11 indexed citations
17.
Li, Yifan, Shiming He, Yonghao Zhan, et al.. (2019). microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5. DNA and Cell Biology. 38(8). 840–848. 12 indexed citations
18.
Ge, Guangzhe, Peng Ding, Bao Guan, et al.. (2019). Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing. Clinical Chemistry. 66(1). 188–198. 33 indexed citations
19.
Fang, Dong, Yanqing Gong, Nirmish Singla, et al.. (2018). The significance of the initial symptom in Chinese patients with upper tract urothelial carcinoma: Regular health examination is still underutilized. The Kaohsiung Journal of Medical Sciences. 34(9). 511–521. 4 indexed citations
20.
Guo, Run‐Qi, Gengyan Xiong, Kaiwei Yang, et al.. (2018). Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study. Urologic Oncology Seminars and Original Investigations. 36(7). 342.e15–342.e23. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangsong Wu Breakdown of academic impact, for papers by Chun‐Dong Zhang Breakdown of academic impact, for papers by Zhonghua Xu Breakdown of academic impact, for papers by Minfeng Chen Breakdown of academic impact, for papers by Jian Dong Breakdown of academic impact, for papers by Chunyan Gu Breakdown of academic impact, for papers by Yan Xie Breakdown of academic impact, for papers by Rui Liu
Rankless by CCL
2026